Compare Mesoblast Limited (MESO) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Warner Music Group Corp — how do they compare? Mesoblast Limited trades at $14.29 (market cap $1.75B), while Warner Music Group Corp trades at $28.72 (market cap $15.12B). The key difference: Warner Music Group Corp is far larger — about 8.6× Mesoblast Limited's market cap, and Warner Music Group Corp pays a 2.77% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Mesoblast Limited for 15 Days and Warner Music Group Corp for 96 Days on average.
| MESO | WMG | |
|---|---|---|
Market Cap | $1.75B | $15.12B |
Volume | 239,027 | 2,966,414 |
Sector | Health | Media |
52-Week High | $20.96 | $34.72 |
52-Week Low | $13.19 | $23.65 |
Typical Hold Time | 15 Days | 96 Days |
Enterprise Value | $1.83B | $19.42B |
Dividend Yield | — | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mesoblast (MESO) trades at $13.75, down 1.36% with bearish technical signals despite recent FDA approval for its Ryoncil potency assay. The company shows significant revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent milestones include completing Phase 3 trials for chronic back pain treatment, positioning the biotech firm for potential market expansion in the $10 billion back pain market.
Investment outlook balances promising commercial progress against persistent financial losses. The stock offers speculative growth potential through FDA-approved therapies and pipeline developments, but carries substantial risk from ongoing cash burn and competitive pressures in the regenerative medicine space.
Warner Music Group (WMG) trades at $28.91, up 2.66% with strong technical momentum and bullish moving average signals. The company reported solid Q2 2026 earnings, beating EPS estimates with $0.38 vs. $0.34 expected, while revenue growth continues with 2026 projections showing $7.3B. Recent AI partnerships with Suno and NetEase Cloud Music highlight strategic positioning in the evolving music industry landscape.
WMG presents a compelling investment case with 66.7% analyst buy ratings and a $39.50 consensus price target representing 36.6% upside. However, risks include recent CFO departure, ongoing AI copyright litigation, and margin pressure from 2025's 5.44% net margin. The stock's premium valuation at 23.12 P/E requires continued execution on streaming growth and AI initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
